International Journal of Cardiology
Volume 145, Issue 2 , Pages 365-367 , 19 November 2010

Androgens and atrial fibrillation: Friends or foes?

  • Tong Liu

      Affiliations

    • Heart Rhythm Center, the Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, 90048, USA
    • Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China
    • ,
  • Michael Shehata

      Affiliations

    • Heart Rhythm Center, the Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, 90048, USA
    • ,
  • Guangping Li

      Affiliations

    • Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China
    • ,
  • Xunzhang Wang

      Affiliations

    • Heart Rhythm Center, the Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, 90048, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 310 423 4856; fax: +1 310 423 6795.

Received 23 December 2009 ,Accepted 14 February 2010.

References 

  1. Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm. 2007;4:S1–S6
  2. Kannel WB, Benjamin EJ. Status of the epidemiology of atrial fibrillation. Med Clin North Am. 2008;92:17–40
  3. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125
  4. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J. 1996;131:790–795
  5. Chen LY, Herron KJ, Tai BC, Olson TM. Lone atrial fibrillation: influence of familial disease on gender predilection. J Cardiovasc Electrophysiol. 2008;19:802–806
  6. Rivero A, Curtis AB. Sex differences in arrhythmias. Curr Opin Cardiol. 2010;25:8–15
  7. Kaushik M, Sontineni SP, Hunter C. Cardiovascular disease and androgens: a review. Int J Cardiol. 2009;
  8. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87:589–598
  9. Stanworth RD, Jones TH. Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res. 2009;37:74–90
  10. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009;5:673–681
  11. Korantzopoulos P, Liu T, Milionis HJ, Li G, Goudevenos JA. ‘Lone’ atrial fibrillation: hunting for the underlying causes and links. Int J Cardiol. 2009;131:180–185
  12. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity—results of a meta-analysis. Am Heart J. 2008;155:310–315
  13. Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009;32:1851–1856
  14. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89:3313–3318
  15. Nettleship JE, Pugh PJ, Channer KS, Jones T, Jones RD. Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease. Horm Metab Res. 2007;39:366–371
  16. Kupelian V, Chiu GR, Araujo AB, Williams RE, Clark RV, McKinlay JB. Association of sex hormones and C-reactive protein levels in men. Clin Endocrinol. 2009;Electronic publication ahead of print
  17. Liu T, Li G. Is atrial fibrillation an inflammatory disease?. Med Hypotheses. 2005;64:1237–1238
  18. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007;115:135–143
  19. Liu T, Li L, Korantzopoulos P, Goudevenos JA, Li G. Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation. Am J Cardiol. 2008;101:1749–1752
  20. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol. 2007;49:1642–1648
  21. Tsuneda T, Yamashita T, Kato T, et al. Deficiency of testosterone associates with the substrate of atrial fibrillation in the rat model. J Cardiovasc Electrophysiol. 2009;20:1055–1060
  22. Vest JA, Wehrens XH, Reiken SR, et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 2005;111:2025–2032
  23. Sood S, Chelu MG, van Oort RJ, et al. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm. 2008;5:1047–1054
  24. Lai J, Zhou D, Xia S, et al. Reduced testosterone levels in males with lone atrial fibrillation. Clin Cardiol. 2009;32:43–46
  25. Traish AM, Abdou R, Kypreos KE. Androgen deficiency and atherosclerosis: the lipid link. Vascul Pharmacol. 2009;51:303–313
  26. Zhang YZ, Xing XW, He B, Wang LX. Effects of testosterone on cytokines and left ventricular remodeling following heart failure. Cell Physiol Biochem. 2007;20:847–852
  27. Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett. 2005;158:167–175
  28. Payne JR, Kotwinski PJ, Montgomery HE. Cardiac effects of anabolic steroids. Heart. 2004;90:473–475
  29. Sullivan ML, Martinez CM, Gallagher EJ. Atrial fibrillation and anabolic steroids. J Emerg Med. 1999;17:851–857
  30. Lau DH, Stiles MK, John B, Shashidhar , Young GD, Sanders P. Atrial fibrillation and anabolic steroid abuse. Int J Cardiol. 2007;117:86–87
  31. Pereira-Junior PP, Chaves EA, Costa ESRH, Masuda MO, de Carvalho AC, Nascimento JH. Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur J Appl Physiol. 2006;96:487–494
  32. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(10)00106-3

doi: 10.1016/j.ijcard.2010.02.039

International Journal of Cardiology
Volume 145, Issue 2 , Pages 365-367 , 19 November 2010

Article Tools